This session provides a non-clinical view of harm reduction, with a particular focus on its intersection with aging. The presenter draws upon her lived experiences from layered perspectives on substance use, mental well-being, HIV, and aging to review models and techniques supporting informed decision-making to define one's personal view of harm reduction. The presentation includes a discussion of some behaviors that support as well as hinder smooth sustainability across one's lifespan. 

Learning Objectives:

At the end of this webinar, you will be able to:

  • Discuss diverse views of harm reduction.
  • Define principles of harm reduction as they apply to aging.
  • Develop a multifaceted harm reduction plan with a focus on clients who are aging.

Faculty: Linda Scruggs, MHS, LPC, SME 

NOTE: This module does NOT offer continuing education credits.


This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.

Please review the content below at your own pace.

Release Date: August 8, 2023 

Expiration Date: August 8, 2024

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Recognize the signs and symptoms of mental health challenges.
    • Describe the influences of cultural and societal stigmas on help-seeking behaviors.
      • List the barriers to treating depression that are unique to men of color.
        • Identify empathetic language to help others facing mental health challenges.
          • Identify appropriate mental health support and substance use services.

          Faculty

          Patrick LeBlanc

          Disclosure of Conflicts of Interest

          Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

          The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

          The faculty presenter has nothing to disclose.

          The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.

          Joint Accreditation Statement

          Jointly Accredited Provider: Interprofessional Continuing EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

          Physician Continuing Medical Education

          The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

          Continuing Nursing Education

          The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

          Continuing Pharmacy Education

          Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

          Continuing Physician Assistant Education

          AAPA Category 1 CMEPostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.


          Continuing Social Work Education

          ACE: approved continuing educationAs a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.

          Continuing Psychologist Education

          Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

          Credit Designation: This program offers 1 continuing education credits for psychologists.

          Interprofessional Continuing Education

          IPCE Interprofessional Continuing Education logoThis activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.



          Disclosure of Unlabeled Use

          This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

          Disclaimer

          Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

          This session explores the impact of stigma on people who have been diagnosed with substance use disorder (SUD) and those who are not clinically diagnosed but display symptoms. The presenter examines the relationship between stigma and systemic racism, as well as racism's compounding effect on access to healthcare services for people who use drugs. The presenter also provides strategies for challenging stigma and misconceptions about SUD.

          Faculty: Mark Robinson

          Learning Objectives:

          At the end of this session, you will be able to:

          • Describe stigma and the impact it has on people who use drugs.
          • Identify how trauma, racial injustice, and historical social constructs have affected communities.
          • Describe ways to respond to drug-use stigma in the workplace and society.

          NOTE: This session does NOT offer continuing education credits.

          This webinar will cover key aspects of faith-based communities' involvement in harm reduction. These include non-judgmental approach, sense of belonging and support, moral and ethical guidance, integrated approach, outreach and awareness, stigma reduction, partnerships with healthcare services, prevention programs, and spiritual healing and transformation. Faculty also will discuss potential challenges that faith-based communities face in addressing complex addiction issues, such as lack of expertise or resources. Faculty will describe strategies for overcoming these challenges by collaborating with professionals, addiction specialists, and evidence-based programs to provide the most effective harm reduction and support services for those struggling with drug use.

          Faculty

          Robert "Bobby" Faison

          Rev. Adalphie Johnson Wilhite, MDiv

          George Kerr, MT-CDSMP/DM


          Learning Objectives

          At the end of this webinar, you will be able to:

          • Describe the benefits of harm reduction work within faith-based institutions.
          • Analyze different forms of stigma in faith-based institutions. 
          • Explain the importance of incorporating people with lived experience into harm reduction programs within faith-based institutions.

          Please note that continuing education credits are not available for this webinar.


          This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.

          Please review the content below at your own pace.

          Release Date: April 6, 2023 

          Expiration Date: April 6, 2024

          Target Audience

          This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.

          Educational Objectives

          After completing this activity, the participant should be better able to:

          • Identify the psychobiosocial/multiple meanings process model of addiction supporting integrative harm reduction therapy (IHRP).
            • Describe harm reduction’s core principles.
              • Explain an overview of IHRP’s seven therapeutic tasks.

              Faculty

              Andrew Tatarsky, Ph. D

              Disclosure of Conflicts of Interest

              Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

              The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

              The faculty presenter has nothing to disclose.

              The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.

              Joint Accreditation Statement

              Jointly Accredited Provider: Interprofessional Continuing EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

              Physician Continuing Medical Education

              The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

              Continuing Nursing Education

              The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

              Continuing Pharmacy Education

              Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

              Continuing Physician Assistant Education

              AAPA Category 1 CMEPostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.


              Continuing Social Work Education

              ACE: approved continuing educationAs a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.

              Continuing Psychologist Education

              Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

              Credit Designation: This program offers 1 continuing education credits for psychologists.

              Interprofessional Continuing Education

              IPCE Interprofessional Continuing Education logoThis activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.



              Disclosure of Unlabeled Use

              This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

              Disclaimer

              Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

              This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.

              Please review the content below at your own pace.

              Release Date: March 30, 2023 

              Expiration Date: March 30, 2024

              Target Audience

              This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.

              Educational Objectives

              After completing this activity, the participant should be better able to:

              • Identify the psychobiosocial/multiple meanings process model of addiction supporting integrative harm reduction psychotherapy (IHRP).
                • Describe harm reduction’s core principles.
                  • Explain an overview of IHRP’s seven therapeutic tasks.

                  Faculty

                  Andrew Tatarsky, Ph. D

                  Disclosure of Conflicts of Interest

                  Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

                  The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

                  The faculty presenter has nothing to disclose.

                  The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.

                  Joint Accreditation Statement

                  Jointly Accredited Provider: Interprofessional Continuing EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

                  Physician Continuing Medical Education

                  The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                  Continuing Nursing Education

                  The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

                  Continuing Pharmacy Education

                  Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

                  Continuing Physician Assistant Education

                  AAPA Category 1 CMEPostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.


                  Continuing Social Work Education

                  ACE: approved continuing educationAs a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.

                  Continuing Psychologist Education

                  Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

                  Credit Designation: This program offers 1 continuing education credits for psychologists.

                  Interprofessional Continuing Education

                  IPCE Interprofessional Continuing Education logoThis activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.



                  Disclosure of Unlabeled Use

                  This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

                  Disclaimer

                  Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

                  This module provides insights on and discusses evidenced-based strategies to promote harm reduction among the youth population. Professionals gain an understanding and knowledge of the foundational principles central to harm reduction, in addition to substance-use trends among youth and strategies and tools to use when working with young adults.

                  Faculty: Keristen Mazyck, LISW-CP, HIVPCP

                  Learning Objectives:

                  At the end of this webinar, you will be able to:

                  • Identify foundational principles central to harm reduction.
                  • Describe harm reduction strategies tailored to youth.
                  • Discuss substance use trends among youth and adolescents.
                  • Discuss the prevalence of substance use among youth. 
                  • Describe harm reduction issues specific to youth experiencing mental and/or behavioral health conditions.

                  NOTE: This module does NOT offer continuing education credits.


                  U=U (undetectable equals untransmissible) refers to how individuals with HIV who have undetectable viral loads cannot transmit HIV. Join DC Engage, led by HealthHIV, on Tuesday, August 29, 2023 at 12:00pm Eastern for a webinar that will provide an in-depth exploration of the U=U concept, with a focus on its application to harm reduction.

                  The module reviews the challenges involved in achieving viral suppression and maintaining undetectable viral loads, particularly for people who use drugs. Providers also gain an understanding of potential opportunities for promoting activities that contribute to harm reduction strategies to reduce barriers and to increase drug user health.

                  Learning Objectives:

                  At the end of this webinar, you will be able to:

                  • Demonstrate enhanced knowledge of U=U (undetectable and untransmissible). 
                  • Describe the limitations to achieving viral suppression and undetectable viral loads. 
                  • Discuss the opportunities and best practices to promote activities that support viral suppression and undetectable viral loads.

                  Faculty: Patrick Ingram and Bobbi Gass, MPH

                  NOTE: This module does NOT offer continuing education credits.

                  This webinar will briefly review the new knowledge gained during the past 50 years. The faculty will describe the shifts in cultural understanding of addiction that have given rise to new research and approaches that can help reduce stigma and discrimination against people with substance use disorders.


                  This course is jointly provided by Postgraduate Institute for Medicine (PIM) and HealthHIV.

                  Please review the content below at your own pace.

                  NOTE: If you seek continuing education credits (CEUs) from PIM after completing the module, you will go to their website and complete a post-course check and an evaluation. If you will not seek credits, you will not need to take a post-course check, but please complete the non-credit evaluation at the end of the module.  Whether or not you seek credits, you will not need to take a pre-course check.

                  Release Date: August 17, 2023 

                  Expiration Date: August 17, 2024

                  UAN  JA4008162-9999-23-287-L02-P

                  Target Audience

                  This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.

                  Educational Objectives

                  After completing this activity, the participant should be better able to:

                  • Identify two dimensions that underlie stigma related to addiction
                    • Recognize and describe the impact of stigma on patient care
                      • Identify three strategies that are helpful to address addiction stigma

                        Faculty

                        Dr. John F. Kelly, PhD, ABPP

                        Disclosure of Conflicts of Interest

                        Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

                        The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

                        The faculty presenter has nothing to disclose.

                        The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.

                        Joint Accreditation Statement

                        Jointly Accredited Provider: Interprofessional Continuing EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

                        Physician Continuing Medical Education

                        The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                        Continuing Nursing Education

                        The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

                        Continuing Pharmacy Education

                        Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

                        Continuing Physician Assistant Education

                        AAPA Category 1 CMEPostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.


                        Continuing Social Work Education

                        ACE: approved continuing educationAs a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.

                        Continuing Psychologist Education

                        Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

                        Credit Designation: This program offers 1 continuing education credits for psychologists.

                        Interprofessional Continuing Education

                        IPCE Interprofessional Continuing Education logoThis activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.



                        Disclosure of Unlabeled Use

                        This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

                        Disclaimer

                        Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.